Synopsis
Synopsis
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Annual Reports
NA
Regulatory FDF Prices
NA
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
1. 50978-11-5
2. Amidotrizoic Acid Dihydrate
3. 3,5-diacetamido-2,4,6-triiodobenzoic Acid Dihydrate
4. Chebi:59733
5. Unii-408463f217
6. Dsstox_cid_28886
7. Dsstox_rid_83154
8. Dsstox_gsid_48960
9. 2,4,6-triiodo-3,5-diacetamidobenzoic Acid Dihydrate
10. 408463f217
11. 3,5-bis(acetylamino)-2,4,6-triiodobenzoic Acid Dihydrate
12. 3,5-diacetamido-2,4,6-triiodobenzoic Acid--water (1/2)
13. Cas-50978-11-5
14. Ncgc00021123-02
15. Amidotrizoic Acid [ban:jan]
16. 3,5-diacetamido-2,4,6-triiodobenzoic Acid;dihydrate
17. Chembl3188504
18. Dtxsid1048960
19. Hms3715h18
20. Act05335
21. Amy33530
22. Tox21_113395
23. Mfcd06408002
24. Akos025310142
25. Tox21_113395_1
26. Ccg-221238
27. Ncgc00021123-03
28. As-13492
29. Ft-0652238
30. Amidotrizoic Acid, Dehydrate [who-ip]
31. D96087
32. 3,5-diacetamido-2,4,6-triiodobenzoicaciddihydrate
33. Amidotrizoic Acid Dihydrate [ep Monograph]
34. Sr-01000003031
35. Sr-01000003031-5
36. Q27126875
37. Acidum Amidotrizoicum, Dehydrate [who-ip Latin]
38. Benzoic Acid, 3,5-bis(acetylamino)-2,4,6-triiodo-, Hydrate (1:2)
1. Amidotrizoic Acid
2. Diatrizoic Acid
3. Diatrizoate
| Molecular Weight | 649.94 g/mol |
|---|---|
| Molecular Formula | C11H13I3N2O6 |
| Hydrogen Bond Donor Count | 5 |
| Hydrogen Bond Acceptor Count | 6 |
| Rotatable Bond Count | 3 |
| Exact Mass | 649.7908 g/mol |
| Monoisotopic Mass | 649.7908 g/mol |
| Topological Polar Surface Area | 97.5 Ų |
| Heavy Atom Count | 22 |
| Formal Charge | 0 |
| Complexity | 391 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 3 |
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
USDMF
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]CEP/COS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results] Digital Content
NEWS #PharmaBuzz
Market Place
ABOUT THIS PAGE
86
PharmaCompass offers a list of Amidotrizoic Acid API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Amidotrizoic Acid manufacturer or Amidotrizoic Acid supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Amidotrizoic Acid manufacturer or Amidotrizoic Acid supplier.
A Diatrizoic Acid Dihydrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Diatrizoic Acid Dihydrate, including repackagers and relabelers. The FDA regulates Diatrizoic Acid Dihydrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Diatrizoic Acid Dihydrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Diatrizoic Acid Dihydrate manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Diatrizoic Acid Dihydrate supplier is an individual or a company that provides Diatrizoic Acid Dihydrate active pharmaceutical ingredient (API) or Diatrizoic Acid Dihydrate finished formulations upon request. The Diatrizoic Acid Dihydrate suppliers may include Diatrizoic Acid Dihydrate API manufacturers, exporters, distributors and traders.
click here to find a list of Diatrizoic Acid Dihydrate suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
A Diatrizoic Acid Dihydrate DMF (Drug Master File) is a document detailing the whole manufacturing process of Diatrizoic Acid Dihydrate active pharmaceutical ingredient (API) in detail. Different forms of Diatrizoic Acid Dihydrate DMFs exist exist since differing nations have different regulations, such as Diatrizoic Acid Dihydrate USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Diatrizoic Acid Dihydrate DMF submitted to regulatory agencies in the US is known as a USDMF. Diatrizoic Acid Dihydrate USDMF includes data on Diatrizoic Acid Dihydrate's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Diatrizoic Acid Dihydrate USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Diatrizoic Acid Dihydrate suppliers with USDMF on PharmaCompass.
A Diatrizoic Acid Dihydrate CEP of the European Pharmacopoeia monograph is often referred to as a Diatrizoic Acid Dihydrate Certificate of Suitability (COS). The purpose of a Diatrizoic Acid Dihydrate CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Diatrizoic Acid Dihydrate EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Diatrizoic Acid Dihydrate to their clients by showing that a Diatrizoic Acid Dihydrate CEP has been issued for it. The manufacturer submits a Diatrizoic Acid Dihydrate CEP (COS) as part of the market authorization procedure, and it takes on the role of a Diatrizoic Acid Dihydrate CEP holder for the record. Additionally, the data presented in the Diatrizoic Acid Dihydrate CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Diatrizoic Acid Dihydrate DMF.
A Diatrizoic Acid Dihydrate CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Diatrizoic Acid Dihydrate CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.
click here to find a list of Diatrizoic Acid Dihydrate suppliers with CEP (COS) on PharmaCompass.
National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Diatrizoic Acid Dihydrate as an active pharmaceutical ingredient (API).
The FDA updates the NDC directory daily. The NDC numbers for Diatrizoic Acid Dihydrate API and other APIs are published in this directory by the FDA.
The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.
Pharmaceutical companies that manufacture Diatrizoic Acid Dihydrate as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.
The NDC directory also contains data on finished compounded human drug products that contain Diatrizoic Acid Dihydrate and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Diatrizoic Acid Dihydrate NDC to their finished compounded human drug products, they may choose to do so.
click here to find a list of Diatrizoic Acid Dihydrate suppliers with NDC on PharmaCompass.
Diatrizoic Acid Dihydrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Diatrizoic Acid Dihydrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Diatrizoic Acid Dihydrate GMP manufacturer or Diatrizoic Acid Dihydrate GMP API supplier for your needs.
A Diatrizoic Acid Dihydrate CoA (Certificate of Analysis) is a formal document that attests to Diatrizoic Acid Dihydrate's compliance with Diatrizoic Acid Dihydrate specifications and serves as a tool for batch-level quality control.
Diatrizoic Acid Dihydrate CoA mostly includes findings from lab analyses of a specific batch. For each Diatrizoic Acid Dihydrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Diatrizoic Acid Dihydrate may be tested according to a variety of international standards, such as European Pharmacopoeia (Diatrizoic Acid Dihydrate EP), Diatrizoic Acid Dihydrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Diatrizoic Acid Dihydrate USP).
